• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussions
  • Patient Centers
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussions
    • Patient Centers
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Janssen

    News Roundup | Johnson & Johnson Single-Dose Vaccine Authorized for Emergency Use

    Article 1 Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study: Johnson & Johnson, announced that the…

    TrialSite Staff
    TrialSite Staff March 1, 2021
    0 Comments
    Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study

    Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study

    Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its…

    TrialSite Staff
    TrialSite Staff February 28, 2021
    0 Comments
    EMA receives application for conditional marketing authorisation of COVID-19 Vaccine Janssen Share

    EMA Receives Application for Conditional Marketing Authorization of COVID-19 Vaccine Janssen

    EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by Janssen-Cilag International N.V. EMA’s human medicines committee (CHMP) will assess the…

    TrialSite Staff
    TrialSite Staff February 17, 2021
    0 Comments
    ENSEMBLE Study Produces Positive Results as Johnson & Johnson Prepares to Submit Emergency Use Authorization for COVID-19 Vaccine Candidate

    ENSEMBLE Study Produces Positive Results as Johnson & Johnson Prepares to Submit Emergency Use Authorization for COVID-19 Vaccine Candidate

    The large Phase 3 ENSEMBLE clinical trial sponsored by Johnson & Johnson (NYSE: JNJ) demonstrates topline efficacy and safety data for the investigational single-dose COVID-19…

    TrialSite Staff
    TrialSite Staff February 5, 2021
    0 Comments
    BARDA-Supported Johnson & Johnson Unit Janssen COVID-19 Vaccine Candidate Gets Closer: Requiring Only 1 Dose & Potential EUA Request May Occur by Feb

    BARDA-Supported Johnson & Johnson Unit Janssen COVID-19 Vaccine Candidate Gets Closer: Requiring Only 1 Dose & Potential EUA Request May Occur by Feb

    TrialSite predicted months ago that the vaccine, sponsored by the world’s largest pharmaceutical company by revenue–Johnson & Johnson, could become the most prominent of COVID-19…

    TrialSite Staff
    TrialSite Staff January 16, 2021
    0 Comments
    St. Jude Children’s Research Hospital & Univ. of TN Health & Science Center Recruit Volunteers for ENSEMBLE Trial: COVID-19 Vaccine from Janssen

    St. Jude Children’s Research Hospital & Univ. of TN Health & Science Center Recruit Volunteers for ENSEMBLE Trial: COVID-19 Vaccine from Janssen

    St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center (UTHSC) now offer a testing site for the Janssen Pharmaceutical Companies of…

    TrialSite Staff
    TrialSite Staff December 5, 2020
    0 Comments
    Emory University Conducts Yet Another Advanced State Trial Targeting COVID-19 Vaccine

    Emory University Conducts Yet Another Advanced State Trial Targeting COVID-19 Vaccine

    Emory University has taken on another major COVID-19 vaccine trial, this time the Phase 3 trial sponsored by the Janssen Pharmaceutical Companies of Johnson &…

    TrialSite Staff
    TrialSite Staff October 31, 2020
    0 Comments
    J&J’s COVID-19 Vaccine Temporarily Paused as Study Participant Falls Ill

    J&J’s COVID-19 Vaccine Temporarily Paused as Study Participant Falls Ill

    Johnson & Johnson has temporarily paused its Phase 3 ENSEMBLE trial due to an unexplained illness in a study participant. This means that the company’s…

    TrialSite Staff
    TrialSite Staff October 13, 2020
    0 Comments
    CTI Trial Site Doses First Subjects for Phase 3 J&J ENSEMBLE COVID-19 Vaccine Trial While Winning Top CRO Award CTI On the Move

    CTI Trial Site Doses First Subjects for Phase 3 J&J ENSEMBLE COVID-19 Vaccine Trial While Winning Top CRO Award: CTI On the Move

    Last week, a globally active, privately held, mid-sized contract research organization (CRO) claims its research site is the very first one to dose a subject…

    TrialSite Staff
    TrialSite Staff October 6, 2020
    0 Comments
    UC San Diego Brings J&J COVID-19 Vaccine Trial to the Southern Districts of the County to Connect with more At Risk & Minority Groups

    UC San Diego Brings J&J COVID-19 Vaccine Trial to the Southern Districts of the County to Connect with more At-Risk & Minority Groups

    UC San Diego Health has joined the third major Phase 3 clinical trial assessing the efficacy and safety of a COVID-19 vaccine candidate. Now they…

    TrialSite Staff
    TrialSite Staff October 3, 2020
    0 Comments
    Load More

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.